RRM2
Ribonucleoside-diphosphate reductase subunit M2
Also known as: C2orf48, FLJ25102, RIR2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P31350
- Gene
- RRM2
- Ensembl
- ENSG00000171848
- Chromosome
- 2
- Canonical length
- 389 aa
- Protein class
- Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes one of two non-identical subunits for ribonucleotide reductase. This reductase catalyzes the formation of deoxyribonucleotides from ribonucleotides. Synthesis of the encoded protein (M2) is regulated in a cell-cycle dependent fashion. Transcription from this gene can initiate from alternative promoters, which results in two isoforms that differ in the lengths of their N-termini. Related pseudogenes have been identified on chromosomes 1 and X. [provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
389 residues, UniProt reviewed canonical sequence.
>P31350|RRM2
1 MLSLRVPLAP ITDPQQLQLS PLKGLSLVDK ENTPPALSGT RVLASKTARR IFQEPTEPKT
61 KAAAPGVEDE PLLRENPRRF VIFPIEYHDI WQMYKKAEAS FWTAEEVDLS KDIQHWESLK
121 PEERYFISHV LAFFAASDGI VNENLVERFS QEVQITEARC FYGFQIAMEN IHSEMYSLLI
181 DTYIKDPKER EFLFNAIETM PCVKKKADWA LRWIGDKEAT YGERVVAFAA VEGIFFSGSF
241 ASIFWLKKRG LMPGLTFSNE LISRDEGLHC DFACLMFKHL VHKPSEERVR EIIINAVRIE
301 QEFLTEALPV KLIGMNCTLM KQYIEFVADR LMLELGFSKV FRVENPFDFM ENISLEGKTN
361 FFEKRVGEYQ RMGVMSSPTE NSFTLDADFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RRM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 54 nTPM
Expression across tissuesHPA
Tissue
- thymus: 54 nTPM
- bone marrow: 42 nTPM
- tonsil: 35 nTPM
- lymph node: 33 nTPM
- rectum: 19 nTPM
- colon: 13 nTPM
Single-cell type
- monocyte progenitors: 409 nCPM
- extravillous trophoblasts: 336 nCPM
- neutrophil progenitors: 279 nCPM
- erythrocyte progenitors: 193 nCPM
- esophageal basal cells: 170 nCPM
- enteric transient amplifying cells: 146 nCPM
Immune cell
- gdT-cell: 1.2 nTPM
- memory CD8 T-cell: 0.8 nTPM
- NK-cell: 0.8 nTPM
- naive CD8 T-cell: 0.4 nTPM
- neutrophil: 0.4 nTPM
- basophil: 0.3 nTPM
Brain region
- choroid plexus: 4.8 nTPM
- thalamus: 2.7 nTPM
- cerebellum: 1.8 nTPM
- cerebral cortex: 1.8 nTPM
- medulla oblongata: 1.7 nTPM
- midbrain: 1.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.75
- gnomAD missense Z
- 2.34
- DepMap mean gene effect
- -2.34
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 2'-deoxyribonucleotide biosynthetic process
- blastocyst development
- deoxyribonucleotide biosynthetic process
- DNA repair
- positive regulation of G1/S transition of mitotic cell cycle
- protein heterotetramerization
- ribonucleoside diphosphate metabolic process
Molecular functions
- ferric iron binding
- protein homodimerization activity
- ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RRM2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RRM2 as an antibody target. Whether an autoantibody or antibody against RRM2 could matter depends on whether native RRM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RRM2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RRM2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...